Salem Investment Counselors’s MaxCyte MXCT Stock Holding History

Salem Investment Counselors’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-56,375	Closed	-$235K	–	1246
2024 Q4	$235K	Hold	56,375	–	–	0.01%	340
2024 Q3	$219K	Hold	56,375	–	–	0.01%	358
2024 Q2	$221K	Hold	56,375	–	–	0.01%	349
2024 Q1	$236K	Buy	56,375 +28,741	+104%	+$135K	0.01%	340
2023 Q4	$130K	Hold	27,634	–	–	﹤0.01%	399
2023 Q3	$86.2K	Hold	27,634	–	–	﹤0.01%	440
2023 Q2	$127K	Hold	27,634	–	–	﹤0.01%	381
2023 Q1	$137K	Buy	27,634 +23,834	+627%	+$117K	0.01%	379
2022 Q4	$20.7K	Hold	3,800	–	–	﹤0.01%	655
2022 Q3	$25K	Buy	+3,800	New	+$21.2K	﹤0.01%	600

Other funds holding MXCT

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.05B AUM 22.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return

Salem Investment Counselors's MXCT Position: Q1 2025 in Review

Salem Investment Counselors sold out of MaxCyte (MXCT) in Q1 2025, closing a stake of 56,375 shares — an estimated $235K sold.

Salem Investment Counselors first reported a position in MXCT in Q3 2022 and held it in 10 quarters. The position peaked at $236K in Q1 2024. 115 funds tracked by Wall St. Rank hold MXCT as of Q1 2025.

Salem Investment Counselors reported no remaining MaxCyte position as of Q1 2025 after selling out during the quarter.
Salem Investment Counselors sold 56,375 MaxCyte shares in Q1 2025, an estimated $235K.
Salem Investment Counselors first reported a position in MaxCyte in Q3 2022 and held it in 10 quarters.
Salem Investment Counselors's MaxCyte position peaked at $236K in Q1 2024.
115 funds tracked by Wall St. Rank held MaxCyte as of Q1 2025.

Based on Salem Investment Counselors's 13F filing for Q1 2025, filed 16 Apr 2025.